Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy
Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy
Active, not recruiting · NCT03843255 · Registry updated 2026-03-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Defining the Genetics, Biomarkers and Outcomes for Dilated Cardiomyopathy | Cardiomegaly, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiomyopathy, cardiovascular disorder, dilated cardiomyopathy, heart disorder, hereditary disease, laminopathy | Active, not recruiting | Not stated | 2026-03-27 | NCT03843255 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| British Heart Foundation | 34 |
| Imperial College London | 220 |
| Royal Brompton & Harefield NHS Foundation Trust | 38 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Glenfield Hospital | Leicester | United Kingdom | 12 |
| Leeds Teaching Hospitals NHS Trust | Leeds | United Kingdom | 6 |
| Liverpool Heart and Chest Hospital Nhs Foundation Trust | Liverpool | United Kingdom | 9 |
| Oxford University Hospitals NHS Foundation Trust | Oxford | United Kingdom | 24 |
| Royal Brompton & Harefield NHS Foundation Trust | London | United Kingdom | 4 |
| Southampton General Hospital | Southampton | United Kingdom | 56 |